# Optimizing Spinal Muscular Atrophy Services
Keywords: Spinal Muscular Atrophy, SMA, UK Rare Diseases Framework, Lean 6 Sigma, Spinraza, nusinersen, specialist care, healthcare pathways, rare diseases, NHS, adverse events

> This page focuses on improving healthcare services for Spinal Muscular Atrophy (SMA) in the UK, providing tailored solutions, educational resources, and tools to support healthcare professionals and enhance patient outcomes.

## Details
- [UK Rare Diseases Framework](#): Overview of the framework published by the Department of Health & Social Care, outlining priorities such as faster diagnosis, better care coordination, and improved access to treatments.
- [Contact Us Today](#): Information on tailored insights and solutions for SMA treatment access, with contact details for Biogen representatives.
- [Lean 6 Sigma Project Manager](#): Support for designing and implementing efficient healthcare pathways using Lean 6 Sigma methodology.
- [Spinraza (nusinersen) Scheduling Tool](#): A tool to manage dosing schedules for SMA patients receiving Spinraza treatments.
- [Business Case Development](#): Assistance in creating business cases by mapping pathways, providing data, and demonstrating value to healthcare commissioners.
- [Specialist Networking Group Support](#): Help in establishing and facilitating specialist networking groups for SMA healthcare professionals.
- [Spinal Muscular Atrophy](#): Details on treatment options for children and adults with SMA.
- [SMA Education](#): Educational resources for healthcare professionals supporting SMA patients.
- [Adverse Event Reporting](#): Instructions for reporting adverse events in the UK and Ireland, including contact details for Biogen and regulatory authorities.